ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Commercial Services

M3, Inc.

Business Summary

M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evidence Solutions segment includes clinical research support business, medical clinical trials management, and management support business. The Overseas segment offers marketing support and research services for medical-related firms in the United States, the United Kingdom, and South Korea. The Clinical Platform segment engages in the development, sale and support of electronic medical records. The Others segment offers information services for medical institutions and prescription drug advertising business. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2021 JPYUSD
Revenue169,198M1,595.34M
Gross Profit103,400M974.94M
Operating income58,362M550.28M
Income before tax58,264M549.36M
Net income37,822M356.61M
EBITDA64,098M604.37M
Diluted EPS55.670.52
Dividends Per Share120.11
Total Assets273,123M2,471.70M
Total liabilities65,863M596.04M
Total equity199,813M1,808.26M
Operating cash flow46,627M439.63M
Currency in JPYCurrency in USD

Historical Data

 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 78,143M 94,471M 113,059M 130,973M 169,198M
Gross Profit 45,444M 53,016M 62,884M 69,759M 103,400M
Operating income 23,985M 26,907M 27,837M 34,294M 58,362M
Income before tax 24,959M 27,472M 30,942M 34,610M 58,264M
Net income 16,004M 18,127M 19,577M 21,635M 37,822M
EBITDA 24,924M 28,068M 29,228M 38,788M 64,098M
Diluted EPS 24.70 27.97 30.20 31.87 55.67
Dividends Per Share 5 5.50 7 8.50 12
Total Assets 95,546M 116,441M 137,306M 221,839M 273,123M
Total liabilities 26,021M 31,272M 35,029M 50,238M 65,863M
Total equity 67,064M 82,483M 98,733M 166,111M 199,813M
Operating cash flow 16,555M 15,913M 17,749M 26,789M 46,627M
 Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue 721.62M 852.37M 1,019.51M 1,204.61M 1,595.34M
Gross Profit 419.66M 478.34M 567.06M 641.60M 974.94M
Operating income 221.49M 242.77M 251.02M 315.41M 550.28M
Income before tax 230.48M 247.86M 279.02M 318.32M 549.36M
Net income 147.79M 163.55M 176.53M 198.98M 356.61M
EBITDA 230.16M 253.24M 263.56M 356.75M 604.37M
Diluted EPS 0.22 0.25 0.27 0.29 0.52
Dividends Per Share 0.04 0.04 0.06 0.07 0.11
Total Assets 857.45M 1,094.88M 1,240.51M 2,054.92M 2,471.70M
Total liabilities 233.51M 294.04M 316.47M 465.36M 596.04M
Total equity 601.84M 775.58M 892.01M 1,538.70M 1,808.26M
Operating cash flow 152.88M 143.57M 160.05M 246.39M 439.63M

Valuation Measures

Mar 2021
PER135.85
ROA15.28%
ROE20.67%
Operating margin34.49%
Profit margin22.35%

Key executives

  • President & Representative Director: Itaru Tanimura

Shareholders

  • Sony Group Corp. (33.9%)
  • Baillie Gifford & Co. (8.2%)
  • Nomura Asset Management Co., Ltd. (5.9%)
  • Harding Loevner LP (3.3%)
  • JPMorgan Asset Management (Japan) Ltd. (3.0%)
  • Nippon Telegraph & Telephone Corp. (2.9%)
  • Nikko Asset Management Co., Ltd. (2.8%)
  • TANIMURA ITARU (2.8%)
  • Daiwa Asset Management Co. Ltd. (2.4%)
  • Capital Research & Management Co. (World Investors) (2.2%)

Contact Details

  • Website:http://corporate.m3.com/
  • Address: Akasaka Intercity, 10/F, 1-11-44 Akasaka, Tokyo, 107-0052, Japan
  • Phone: +81.3.6229.8900

Related Companies

  • M3, Inc. /Fund OPD/
  • Towa Sangyo Co., Ltd. (Osaka)
  • ONEhealth Communications Ltd.
  • Vidal France SA
  • M3 (EU) Ltd.
  • M3 Medical Holdings Ltd.
  • Medical Agency KK
  • Edanz Group Japan, Inc.
  • Neuroglia Health Pvt Ltd.
  • Shin Nippon Biomedical Laboratories SMO Ltd.
  • iG-Holdings, Inc. (Japan)
  • M3 Doctor Support, Inc.
  • M3i, Inc.
  • Clinical Porter, Inc.
  • Nouvelle Place, Inc.
  • M3 Marketing, Inc.
  • DailyRounds, Inc.
  • e- SMO KK
  • M Cube, Inc.
  • Fuji CRS KK
  • QLife, Inc.
  • M3 USA Corp.
  • Medi C&C Co., Ltd.
  • C.M.S Co. Ltd.
  • Nihon Ultmarc, Inc.
  • Cosmotec Co., Ltd.
  • SmartestDoc LLC
  • Neues Co. Ltd.
  • Manthan Software Services Pvt Ltd.
  • MIC Medical Corp.

Competitors

    Last Updated on 7 May, 2021

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

    Stay ahead with our exclusives on Asia;
    the most dynamic market in the world.

    Stay ahead with our exclusives on Asia

    Get trusted insights from experts within Asia itself.

    Get trusted insights from experts
    within Asia itself.

    Try 1 month for $0.99

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

    This is your last free article this month

    Stay ahead with our exclusives on Asia; the most
    dynamic market in the world
    .

    Get trusted insights from experts
    within Asia itself.

    Try 3 months for $9

    Offer ends January 31st

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to Nikkei Asia has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more